Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PerkinElmer to Host Revolutionaries for Global Health Summit

Published: Wednesday, May 01, 2013
Last Updated: Wednesday, May 01, 2013
Bookmark and Share
Company to assemble thought leaders to share pioneering personalized health research and innovations.

PerkinElmer Inc. is hosting a Revolutionaries for Global Health Summit from Wednesday May 8th through Thursday May 9th 2013 at the Boston Marriot Newton Hotel. The Summit is a forum for leading researchers and physicians to network and share best practices in both science and business and participate in cutting-edge discussions to help lead to better prevention, detection and treatment of disease. The meeting program will feature world-renowned experts presenting key insights on finding, understanding, and acting upon the causes and effects of disease including cancer, diabetes and heart disease.

“From Cradle to Grave, Health is Personal.”

"The Revolutionaries for Global Health Summit is a unique forum that fosters collaboration and shares research on how to use disruptive technologies to enable the advancement of human health. Recognized scientific leaders from biotech, pharma and academia will discuss their strategies and insights on how to enable better approaches for disease prevention, diagnosis and screening regimens, creating safer and more effective personalized therapeutics," said Kevin Hrusovsky, President, Life Sciences & Technology, PerkinElmer. “Once again, we look forward to bringing together hundreds of scientists from throughout leading research institutions around the world to the Boston area to share valuable insights and spark innovative discussions.”

The Summit will feature notable keynote presentations:
•    A presentation titled, “Quantitative Human Phenotyping: The Next Frontier,” will be given by Dennis A. Ausiello, MD, Physician-in-Chief at Massachusetts General Hospital.
•    Charles Mattocks, host of the TV Show “The Poor Chef”, will be sharing insights on a new movement called The Diabetic You, and how lifestyle and eating choices can complement modern medicine. In addition, he will be overseeing the preparation of all the food at the event to make sure that is not only delicious, but also healthy.
•    Dr. Richard Baum, Chairman and Clinical Director of THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, will present “Personalized Molecular Targeted Radiotherapy of Cancer.”
•    Kevin Hrusovsky will present, “From Cradle to Grave, Health is Personal.” In the past year, PerkinElmer has made tremendous progress in the fight against cancer and disease. This talk will focus on how technology has contributed to this progress.

Attendees will have the opportunity to participate in six informative tracks in the following areas: next generation sequencing, in vivo imaging, targeted small molecule discovery, proteins and biologics, tissue and cellular imaging/molecular pathology and enabling and accelerating science through laboratory services and informatics.

In support of PerkinElmer’s vision of preventing disease, the American Cancer Society will be at the summit sharing information and recruiting volunteers for their cancer prevention study.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PerkinElmer Revenues Grow 4%
PerkinElmer, Inc. reported financial results for the fourth quarter ended December 29, 2013.
Monday, February 03, 2014
PerkinElmer Announces Collaboration with Rutgers University Cell and DNA Repository
Companies team up to enable large-scale sequencing studies through more efficient automation and improving next generation sequencing sample access.
Tuesday, February 21, 2012
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Genetic Test Could Improve Blood Cancer Treatment
Testing for genetic risk factors could improve treatment for myeloma – a cancer of the blood and bone marrow – by helping doctors identify patients at risk of developing more aggressive disease.
PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!